Related Experiment Video
Updated: Aug 25, 2025

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
Rational consideration of Akkermansia muciniphila targeting intestinal health: advantages and challenges
Yuheng Luo1, Cong Lan2, Hua Li2
1Animal Nutrition Institute, Sichuan Agricultural University, Key Laboratory for Animal Disease-Resistance Nutrition of Ministry of Education of China, Key Laboratory for Animal Disease-Resistance Nutrition and Feed of Ministry of Agriculture of China, Key laboratory of Animal Disease-resistant Nutrition of Sichuan Province, Chengdu, 611130, China. luoluo212@126.com.
Abstract:
As one of the promising next-generation probiotics (NGPs), Akkermansia muciniphila, a well-known mucin-degrading bacterium, has been proven to be closely related to the metabolic diseases of its human host. However, the role of A. muciniphila in the host's intestinal health remains ambiguous. Here, we comprehensively summarize and discuss the characteristics, the distribution, and the colonization of A. muciniphila in the human gastrointestinal tract (GIT). We propose that the application of A. muciniphila as a biomarker for longevity, for diagnostics and prognostics of intestinal diseases, or for intestinal health should be cautiously considered. Precise dietary regulation can mediate the treatment of intestinal diseases by altering the abundance of A. muciniphila. Although the beneficial role of A. muciniphila and its component in intestinal inflammation has been discovered, in gnotobiotic mice with specific gut microbiota, certain genotype, and colorectal cancer, or in animal models infected with a specific pathogen, A. muciniphila may be related to the occurrence and development of intestinal diseases. Genomic analysis, emphasizing the strain-level phylogenetic differences of A. muciniphila, indicates that a clear description and discussion of each strain is critical before its practical application. Our review provides much needed insight for the precise application of A. muciniphila.
Insights
Akkermansia muciniphila, a next-generation probiotic, has a complex role in gut health and disease. Its application requires careful consideration of strain differences and host factors for safe and effective use.
Area of Science:
- Microbiology
- Gastroenterology
- Probiotics Research
Background:
- Akkermansia muciniphila is a next-generation probiotic known for degrading mucin.
- Its association with metabolic diseases is established, but its precise role in intestinal health is unclear.
- Understanding A. muciniphila's characteristics, distribution, and colonization is crucial.
Purpose of the Study:
- To comprehensively review A. muciniphila's characteristics, distribution, and colonization in the human gut.
- To evaluate the potential applications of A. muciniphila as a biomarker or therapeutic agent.
- To highlight the importance of strain-level genomic analysis for its practical use.
Main Methods:
- Literature review and synthesis of existing research on Akkermansia muciniphila.
- Analysis of genomic data to understand strain-level phylogenetic differences.
- Discussion of A. muciniphila's role in various intestinal conditions and host interactions.
Main Results:
- A. muciniphila's role in intestinal health is complex and context-dependent.
- Dietary interventions can modulate A. muciniphila abundance for disease treatment.
- Potential benefits in inflammation contrast with possible links to diseases like colorectal cancer in specific contexts.
Conclusions:
- Cautious consideration is needed for A. muciniphila's application as a biomarker or for intestinal health.
- Strain-specific genomic information is critical before widespread application.
- Further research is needed for precise and safe utilization of A. muciniphila.
More Related Videos
06:04Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease
Published on: February 9, 2016
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Related Concept Videos
What is Monogastric Digestion?
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Stomach pH Regulation
The acid-secreting gastric mucosal epithelial cells (parietal cells) lining the stomach lumen maintain the low pH in the lumen. Numerous ion transporters and channels on these parietal...
Defense Mechanism Against Infection
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...